后玻璃体脱离评估及视网膜脱离预防的成本-效用分析
该研究采用决策分析模型,基于已发表的回顾性自然病程数据和美国医疗保险与医疗补助服务中心(CMS)费用数据,评估后玻璃体脱离(PVD)检查及相关病变治疗、以及其他周边视网膜病变预防视网膜脱离(RD)的成本-效用。结果显示,急性PVD评估及症状性马蹄形裂孔治疗成本低且成本-效用良好,支持现行实践标准。
要点
- 急性PVD评估及症状性马蹄形裂孔治疗成本低、成本-效用良好,支持现行实践标准。
- 在医疗机构/医院(非医疗机构/门诊手术中心)场景下,PVD评估及关联病变治疗的单次或两次检查方案成本为65至190美元(25至71美元)。
- 治疗无症状马蹄形裂孔为每质量调整生命年(QALY)2981美元(1436美元/QALY),治疗对侧眼有RD史的无症状格子样变性为4414美元/QALY(2187美元/QALY)。
核心结论
- 急性PVD评估及症状性马蹄形裂孔治疗成本低且成本-效用良好(低美元/QALY),因减少了RD发生相关的成本和疾病负担,从而支持现行实践标准。
研究设计与样本
- 成本-效用决策分析模型,无参与者,使用已发表的PVD、视网膜裂孔和格子样变性自然病程回顾性数据以及CMS费用数据。
主要发现
- 在医疗机构/医院(非医疗机构/门诊手术中心)场景下,PVD评估及关联病变治疗的成本为65至190美元(25至71美元),取决于采用单次或两次检查方案。
- 每挽救QALY的成本为255至638美元/QALY(100至239美元/QALY)。
- 治疗症状性马蹄形裂孔净节省成本1749美元(1314美元)并改善效用,而治疗无症状马蹄形裂孔为2981美元/QALY(1436美元/QALY)。
- 治疗对侧眼有RD史的无症状格子样变性为4414美元/QALY(2187美元/QALY)。
临床怎么用
- 原文结论认为急性PVD评估及症状性马蹄形裂孔治疗成本低且成本-效用良好,从而支持现行实践标准。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the costs and cost-utility of examination for posterior vitreous detachment (PVD) and treatment of associated pathology, and of managing various other peripheral retinal disorders to prevent retinal detachment (RD). DESIGN: A decision analysis model of cost-utility. PARTICIPANTS: There were no participants. METHODS: Published retrospective data on the natural course of PVD, retinal tears, and lattice degeneration were used to quantitate the visual benefits of examination and treatment. Center for Medicare and Medicaid Services data were used to calculate associated modeled costs in a hospital/facility-based and nonfacility/ambulatory surgical center (ASC)-based setting. Published standards of utility for a given level of visual acuity were used to derive costs and quality-adjusted life years (QALYs). MAIN OUTCOME MEASURES: Cost of evaluation and treatment, utility of defined health states, QALY, and cost per QALY. RESULTS: The modeled cost of evaluation of a patient with PVD and treatment of associated pathology in the facility/hospital (nonfacility/ASC)-based setting was $65 to $190 ($25-$71) depending on whether a single or 2-examination protocol was used. The cost per QALY saved was $255 to $638/QALY ($100-$239/QALY). Treatment of a symptomatic horseshoe tear resulted in a net cost savings of $1749 ($1314) and improved utility, whereas treatment of an asymptomatic horseshoe tear resulted in $2981/QALY ($1436/QALY). Treatment of asymptomatic lattice degeneration in an eye in which the fellow eye had a history of RD resulted in $4414/QALY ($2187/QALY). CONCLUSIONS: Evaluation and management of incident acute PVD (and symptomatic horseshoe tears) offer a low cost and a favorable cost-utility (low $/QALY) as a result of the minimization of the cost and morbidity associated with the development of RD, thus justifying current practice standards.
引用
- Yannuzzi NA, Chang JS, Brown GC, et al. Cost-Utility of Evaluation for Posterior Vitreous Detachment and Prophylaxis of Retinal Detachment. Ophthalmology. 2017. PMID: 28732590. doi:10.1016/j.ophtha.2017.06.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。